Before the bell, several companies were in the spotlight. Align Technology saw its shares rise 2.5% following a buy rating with HSBC citing the Invisalign maker's strong brand and potential for market share growth in digital orthodontics. Hewlett Packard Enterprise, however, decreased nearly 2%, after the company reported adjusted earnings of 49 cents per share, beating a Refinitiv estimate by 2 cents, and revenue of $7 billion in line with expectations. Insulet stock surged 4.4% after CEO James Hollingshead bought 5,550 shares and the company also announced the launch of an insulin delivery system called Omnipod 5 in Germany. In contrast, Box saw its stock plummet 10.2% due to a mixed second-quarter report and weak top- and bottom-line forecast. Texas Instruments dipped almost 2.1% after Bernstein downgraded the semiconductor stock, citing the strategies to produce in-house chips. HP experienced a 0.7% rise following the company's fiscal third quarter revenue miss, yet earnings per share hit analyst predictions. Ambarella dropped 20% or more due to a below target forward guidance, while PVH gained 2.6% after a stronger than expected earnings report and reaffirmed full-year revenue guidance and increased its outlook for earnings per share. — CNBC's Samantha Subin, Yun Li and Sarah Min contributed reporting.
Comments